Animal Drug Compounding Market Revenue to Surpass US$ 1.5 Bn by 2029 End; Oral Formulations to Contribute a Major Revenue Share, Says PMR

An increase in the number of FDA-approved drugs for animals has a major influence on the growth of the animal drug compounding market. Self-nomination for drug inspection is taking shape of a mainstream practice encouraging the adoption of drug compounding in the market.


New York, United States, March 30, 2020 (GLOBE NEWSWIRE) -- The global animal drug compounding market is set to witness robust growth during the forecast period. Market players are making investments to get the compounding product approval from FDA. manufacturers are making drug compounding lucrative by introducing unique and exotic flavors in them. Such developments are enhancing the popularity of animal drug compounding amongst the consumers, strengthening its growth trajectory.

Animal Drug Compounding Market: Key Takeaways

  • Hormonal drugs will gain rapid traction in the market for their ability to influence the emotions in animals. 
  • The high adoption rate of companion drugs will have a major contribution to the revenue in the market through 2019-2029.
  • Orally formulation of drugs will account for 80% of the market revenue by the end of 2029.
  • The injectable segment in formulations will grow at a rapid pace during the forecast period.
  • North America will stay at the forefront in the market owing to a rapid surge in the adoption of compounded drugs.

Request for sample report: https://www.persistencemarketresearch.com/samples/12871

Animal Drug Compounding Market: Key Growth Drivers

  • The ability to use the desired active ingredient in the compounded drugs is increasing the popularity of animal drug compounding.
  • The unavailability of FDA-approved drugs for many animal diseases encourages the adoption of animal drug compounding, boosting the growth in the market.
  • Regulatory inspections ensure the standard practice of drug manufacturing in the animal drug compounding market, making drug compounding a safe process.
  • Growth in the number of animal drug compounding facilities provides impetus to the market for growth.
  • Flavored drug compounding products are witnessing high demand in the market, positively influencing the overall revenue generated in the market.

Animal Drug Compounding Market: Key Restraints

  • Adverse effects and risks associated with animal drug compounding products challenge robust market growth.
  • Lack of uniform standards for animal drug compounding at a global level is a major market restraining factor.

The complete animal drug compounding market report with detailed market segmentation, 84 illustrative figures, and 33 data tables spread across 163 pages on  https://www.persistencemarketresearch.com/methodology/12871

Animal Drug Compounding Market: Competition Landscape
Market players are taking the help of government approvals to add authenticity to their drug compounding products in the market. They are developing new products to capture rare ailments in animals that lack medicines in the market. Unique and tasty flavors of animal drug compounding provide enhanced market penetration to the market players.

Get Persistence Market Research’s Detailed Coverage On
Ostomy Care Accessories Market: PMR’s new report on the global ostomy care accessories market gives an intensive analysis of the market projected to witness robust progress through 2019-2029. The report also provides an elaborated evaluation of major growth determinants, potential revenue resources, and market participants with their popular products.

Human Platelet Lysate Market: Get in-depth analytical insight on the global human platelet lysate market with vital statistics on major market segments, profitable growth opportunities, burgeoning market challenges, government involvement, region-based market forecast, and key strategic partnerships of key market players.

dysphagia diet thickening agents market: Get substantial details on the global dysphagia diet thickening agents market with detailed segment-based analysis, market growth enhance, regional forecast and major players with their key business strategies.

Gain access to Market Ngage, an AI-powered, real-time business intelligence platform that goes beyond the conventional research solution to solve the complex strategic challenges that organizations face today.
                     
About the Report
Persistence Market Research report is about unique and actionable insights on the animal drug compounding market, which includes historical demand statistics for 2014-2018 and market health projections for 2019-2029, based on the animal type (livestock, companion animals), product type (hormones and substitutes, CNS agents, anti-inflammatory agent, and anti-infective agents), formulation (injectable, oral), in seven major regions.

About Persistence Market Research
Persistence Market Research (PMR) is an innovative and specialized supplier of market intelligence reports and consulting services. Prompt delivery, in-depth research, and high quality are the sacrosanct principles of PMR. The company’s research capabilities cover 5 continents, 1500+ reports, and 8 next-gen vertical expertise that have been catering to research demands of 5000+ clients.

Contact:       
Rajendra Singh
Persistence Market Research
U.S. Sales Office:
305 Broadway, 7th Floor
New York City, NY 10007
+1-646-568-7751
United States
USA - Canada Toll-Free: 800-961-0353
For Sales Enquiries: sales@persistencemarketresearch.com
For Media Enquiries: media@persistencemarketresearch.com
Research Report: https://www.persistencemarketresearch.com/market-research/animal-drug-compounding-market.asp
Press Release Source: https://www.persistencemarketresearch.com/mediarelease/animal-drug-compounding-market.asp